Malin Lindstedt
Lund university
Key Publications
1. ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell–dependent tumor immunity and synergizes with PD-1 blockade. Accepted for publication in Cancer Immunology Research.
2. Considerations and Software for Successful Immune Cell Deconvolution Using Proteomics Data. Zamore M, Mosquim Junior S, Andree S, Altunbulakli C, Lindstedt M, Levander F. J Proteome Res. 2025 Aug 1;24(8):3751-3761. doi: 10.1021/acs.jproteome.4c00868.
3. Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. Jimenez DG, Altunbulakli C, Swoboda S, Sobti A, Askmyr D, Ali A, Greiff L, Lindstedt M. Front Immunol. 2023 Jan 19;13:1087843. doi: 10.3389/fimmu.2022.1087843.